These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 21310253)

  • 1. IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis.
    Chen L; Li DQ; Zhong J; Wu XL; Chen Q; Peng H; Liu SQ
    Osteoarthritis Cartilage; 2011 Jun; 19(6):711-8. PubMed ID: 21310253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.
    Alvarez-Soria MA; Largo R; Santillana J; Sánchez-Pernaute O; Calvo E; Hernández M; Egido J; Herrero-Beaumont G
    Ann Rheum Dis; 2006 Aug; 65(8):998-1005. PubMed ID: 16476713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
    Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
    Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels.
    Schelbergen RF; van Dalen S; ter Huurne M; Roth J; Vogl T; Noël D; Jorgensen C; van den Berg WB; van de Loo FA; Blom AB; van Lent PL
    Osteoarthritis Cartilage; 2014 Aug; 22(8):1158-66. PubMed ID: 24928317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment.
    de Boer TN; Huisman AM; Polak AA; Niehoff AG; van Rinsum AC; Saris D; Bijlsma JW; Lafeber FJ; Mastbergen SC
    Osteoarthritis Cartilage; 2009 Apr; 17(4):482-8. PubMed ID: 18926729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients.
    Deligne C; Casulli S; Pigenet A; Bougault C; Campillo-Gimenez L; Nourissat G; Berenbaum F; Elbim C; Houard X
    Osteoarthritis Cartilage; 2015 Nov; 23(11):1843-52. PubMed ID: 26521730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
    Chabaud M; Durand JM; Buchs N; Fossiez F; Page G; Frappart L; Miossec P
    Arthritis Rheum; 1999 May; 42(5):963-70. PubMed ID: 10323452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of Celecoxib on inflammation and synovial microcirculation in murine antigen-induced arthritis.
    Gebhard HH; Zysk SP; Schmitt-Sody M; Jansson V; Messmer K; Veihelmann A
    Clin Exp Rheumatol; 2005; 23(1):63-70. PubMed ID: 15789889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1beta.
    Lee HS; Lee CH; Tsai HC; Salter DM
    Osteoarthritis Cartilage; 2009 Jan; 17(1):91-9. PubMed ID: 18573668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparameter Analysis Identifies Heterogeneity in Knee Osteoarthritis Synovial Responses.
    Labinsky H; Panipinto PM; Ly KA; Khuat DK; Madarampalli B; Mahajan V; Clabeaux J; MacDonald K; Verdin PJ; Buckner JH; Noss EH
    Arthritis Rheumatol; 2020 Apr; 72(4):598-608. PubMed ID: 31702112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease.
    Scanzello CR; Umoh E; Pessler F; Diaz-Torne C; Miles T; Dicarlo E; Potter HG; Mandl L; Marx R; Rodeo S; Goldring SR; Crow MK
    Osteoarthritis Cartilage; 2009 Aug; 17(8):1040-8. PubMed ID: 19289234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
    Gallelli L; Galasso O; Falcone D; Southworth S; Greco M; Ventura V; Romualdi P; Corigliano A; Terracciano R; Savino R; Gulletta E; Gasparini G; De Sarro G
    Osteoarthritis Cartilage; 2013 Sep; 21(9):1400-8. PubMed ID: 23973155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis.
    Takahashi K; Goomer RS; Harwood F; Kubo T; Hirasawa Y; Amiel D
    Osteoarthritis Cartilage; 1999 Mar; 7(2):182-90. PubMed ID: 10222217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
    van Lent PL; Blom AB; Schelbergen RF; Slöetjes A; Lafeber FP; Lems WF; Cats H; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2012 May; 64(5):1466-76. PubMed ID: 22143922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis.
    Bondeson J; Wainwright SD; Lauder S; Amos N; Hughes CE
    Arthritis Res Ther; 2006; 8(6):R187. PubMed ID: 17177994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts.
    Kusunoki N; Ito T; Sakurai N; Suguro T; Handa H; Kawai S
    J Pharmacol Exp Ther; 2005 Aug; 314(2):796-803. PubMed ID: 15870389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.
    Knorth H; Dorfmüller P; Lebert R; Schmidt WE; Wittenberg RH; Heukamp M; Wiese M; Willburger RE
    Osteoarthritis Cartilage; 2004 Aug; 12(8):658-66. PubMed ID: 15262246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.